Ocugen Statistics

Total Valuation

Ocugen has a market cap or net worth of $209.37 million. The enterprise value is $183.36 million.

Market Cap	209.37M
Enterprise Value	183.36M

Important Dates

The next estimated earnings date is Tuesday, May 13, 2025, before market open.

Earnings Date	May 13, 2025
Ex-Dividend Date	n/a

Share Statistics

Ocugen has 292.01 million shares outstanding. The number of shares has increased by 10.92% in one year.

Current Share Class	292.01M
Shares Outstanding	292.01M
Shares Change (YoY)	+10.92%
Shares Change (QoQ)	+4.58%
Owned by Insiders (%)	1.59%
Owned by Institutions (%)	24.59%
Float	287.37M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	47.92
Forward PS	n/a
PB Ratio	7.05
P/TBV Ratio	7.07
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	45.22
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 2.86, with a Debt / Equity ratio of 1.10.

Current Ratio	2.86
Quick Ratio	2.71
Debt / Equity	1.10
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -154.01% and return on invested capital (ROIC) is -62.43%.

Return on Equity (ROE)	-154.01%
Return on Assets (ROA)	-46.57%
Return on Invested Capital (ROIC)	-62.43%
Return on Capital Employed (ROCE)	-89.98%
Revenue Per Employee	$42,684
Profits Per Employee	-$568,989
Employee Count	95
Asset Turnover	0.06
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -41.94% in the last 52 weeks. The beta is 3.80, so Ocugen's price volatility has been higher than the market average.

Beta (5Y)	3.80
52-Week Price Change	-41.94%
50-Day Moving Average	0.65
200-Day Moving Average	0.96
Relative Strength Index (RSI)	55.66
Average Volume (20 Days)	4,024,740

Short Selling Information

The latest short interest is 65.79 million, so 22.53% of the outstanding shares have been sold short.

Short Interest	65.79M
Short Previous Month	67.51M
Short % of Shares Out	22.53%
Short % of Float	22.90%
Short Ratio (days to cover)	15.53

Income Statement

In the last 12 months, Ocugen had revenue of $4.05 million and -$54.05 million in losses. Loss per share was -$0.20.

Revenue	4.05M
Gross Profit	-28.07M
Operating Income	-54.76M
Pretax Income	-50.86M
Net Income	-54.05M
EBITDA	-52.79M
EBIT	-54.76M
Loss Per Share	-$0.20

Full Income Statement

Balance Sheet

The company has $58.51 million in cash and $32.50 million in debt, giving a net cash position of $26.01 million or $0.09 per share.

Cash & Cash Equivalents	58.51M
Total Debt	32.50M
Net Cash	26.01M
Net Cash Per Share	$0.09
Equity (Book Value)	29.63M
Book Value Per Share	0.10
Working Capital	40.09M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$42.14 million and capital expenditures -$3.39 million, giving a free cash flow of -$45.53 million.

Operating Cash Flow	-42.14M
Capital Expenditures	-3.39M
Free Cash Flow	-45.53M
FCF Per Share	-$0.16

Full Cash Flow Statement

Margins

Gross Margin	n/a
Operating Margin	-1,350.36%
Pretax Margin	-1,333.02%
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

Ocugen does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-10.92%
Shareholder Yield	-10.92%
Earnings Yield	-25.82%
FCF Yield	-21.74%

Analyst Forecast

The average price target for Ocugen is $6.33, which is 779.29% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$6.33
Price Target Difference	779.29%
Analyst Consensus	Strong Buy
Analyst Count	3
Revenue Growth Forecast (5Y)	185.99%
EPS Growth Forecast (5Y)	n/a

Stock Forecasts

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Ocugen has an Altman Z-Score of -3.75 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-3.75
Piotroski F-Score	2